It is also interesting to note that there were two studies of in vivo mouse models of acute asthma and COPD which showed that recombinant FGF2 (rFGF2) is protective against airway inflammation and lung function, rather than enhancing inflammation (Jeon et al., 2007; Kim et al., 2018). This evidence concerns the gene FGF2 and asthma.